Petition Fast-Track For COVID-19-Related Appeals Pilot Program {PTO-SB-454}

PTO/SB/454, PETITION Fast-Track for COVID-19-Related Appeals Pilot Program, A COVID-related appeal for eligibility into the pilot program must relate to a product or process that is subject to an applicable U.S. Food and Drug Administration (FDA) approval for COVID-19 use. Petition grants for fast-track review of COVID-related ex parte appeals will be limited to a maximum of 500, and the USPTO has a goal to issue a decision for these appeals within six months of entry into the pilot program. In order to keep appeals on schedule, oral hearings under the program will be expedited and, once scheduled, will not be rescheduled or relocated. www.FormsWorkflow.com